Samuel Waksal's dream of winning FDA approval for his cancer drug Erbitux became reality Thursday, but neither Waksal nor his friend decorating expert Martha Stewart will likely be at the party celebrating the pending launch of the biologic developed by ImClone Systems Inc. (BioWorld Today)

Samuel Waksal's dream of winning FDA approval for his cancer drug Erbitux became reality Thursday, but neither Waksal nor his friend decorating expert Martha Stewart will likely be at the party celebrating the pending launch of the biologic developed by ImClone Systems Inc. (BioWorld Today)